Alaunos Therapeutics, Inc. · NASDAQ:TCRT
Price Adrian reported a 8.60% stake in Alaunos Therapeutics, Inc. (Schedule 13D/A)
Event Oct 30, 2025 · Filed Oct 31, 2025
Price Adrian reported a 8.60% stake in Alaunos Therapeutics, Inc., 189,061 shares, with active intent on Oct 30, 2025. Filed Oct 31, 2025 (Schedule 13D/A).
- Stake
- 8.60%
- Shares
- 189,061
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 18 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Chris Butterworth | 0.50% | 10,700 |
| Richard Jones | 0.70% | 16,000 |
| Edward Jones | 0.50% | 11,750 |
| Gareth Downing | 0.90% | 19,522 |
| Richard Kotey | 0.60% | 12,530 |
| Chris Cole | 0.70% | 15,856 |
| Arif Chaudrey | 0.30% | 6,423 |
| Emma Babb | 0.50% | 10,366 |
| Colin Craig | 0.30% | 7,000 |
| John Nicholls | 0.80% | 16,743 |
| Carl Ware | 0.10% | 1,721 |
| Andrew Turner | 0.60% | 13,035 |
| Matthew Robbins | 0.50% | 10,036 |
| Phillip James Stead | 0.50% | 11,012 |
| Stephen Hennessy | 0.30% | 7,108 |
| Greg Arnold | 0.50% | 10,735 |
| Michelle Douglas | 0.40% | 8,494 |
| Price Adrian | 8.60% | 189,061 |
Source
Related
- Alaunos Therapeutics, Inc.
- Price Adrian
- Alaunos Therapeutics, Inc. shareholders
- Schedule 13D/A · Price Adrian · Mar 5, 2026
- Schedule 13D/A · Price Adrian · Feb 24, 2026
- Schedule 13D/A · Price Adrian · Dec 5, 2025
- Schedule 13D · Price Adrian · Oct 30, 2025
- Schedule 13D · Fairmount Funds Management LLC · Oct 15, 2026
- Schedule 13D/A · Postma Robert W · Oct 15, 2026
- Form 4 · Postma Robert W · Oct 8, 2026
- Form 4 · Weis Holger · Oct 8, 2026
- Form 4 · Vieser Jaime · Oct 8, 2026